Hedge Funds Can't Access Shares To Satisfy $21M Award
Four hedge funds cannot scoop up American Oriental Bioengineering Inc.'s shares in another drug company to satisfy a $21 million default judgment, a New Jersey appeals court held Friday, saying the...To view the full article, register now.
Already a subscriber? Click here to view full article